RNAC
What one share of Cartesian Therapeutics holds
Pharmaceutical Preparations
The Company (formerly known as Selecta Biosciences, Inc., or Selecta) was incorporated in Delaware on December 10, 2007, and is headquartered in Frederick, Maryland.
Cartesian Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.05 |
|---|---|
| Profit | −$5.61 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | −$2.90 |
| Cash and investments | $4.91 |
| Debt | $1.76 |
| Book value | −$4.17 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $23.11 | −$116.57 | $1.68 | −$58.16 | — | $89.42 |
| 2017 | $0.30 | −$95.94 | $1.08 | −$77.49 | — | $69.57 |
| 2018 | $1.21 | −$87.55 | $1.18 | −$80.46 | — | −$7.23 |
| 2019 | $4.40 | −$36.46 | $0.03 | −$33.91 | — | $2.92 |
| 2020 | $4.92 | −$20.42 | $0.24 | $10.10 | — | −$5.00 |
| 2021 | $22.32 | −$6.74 | $0.28 | −$16.13 | — | $5.47 |
| 2022 | $22.78 | $2.98 | $0.25 | −$6.75 | — | $18.39 |
| 2023 | $5.03 | −$49.76 | $0.04 | −$9.94 | — | −$81.55 |
| 2024 | $2.24 | −$4.49 | $0.52 | −$1.89 | — | −$0.26 |
| 2025 | $0.11 | −$5.02 | $0.21 | −$3.06 | — | −$4.85 |